PCNA AND KI-67 LABELING INDEXES IN PRE-IRRADIATED AND POST-IRRADIATEDASTROCYTOMAS - A COMPARATIVE IMMUNOHISTOCHEMICAL ANALYSIS FOR EVALUATION OF PROLIFERATIVE ACTIVITY
E. Pierce et al., PCNA AND KI-67 LABELING INDEXES IN PRE-IRRADIATED AND POST-IRRADIATEDASTROCYTOMAS - A COMPARATIVE IMMUNOHISTOCHEMICAL ANALYSIS FOR EVALUATION OF PROLIFERATIVE ACTIVITY, Journal of clinical pathology-Molecular pathology, 51(2), 1998, pp. 90-95
Aim-To determine the tumour proliferative activity in a series of arch
ival cerebral astrocytomas and compare proliferating cell nuclear anti
gen (PCNA) and Ki-67 labelling indices in the primary and recurring ne
oplasms following therapeutic radiation. Method-Twenty eight cases of
preirradiated and post-irradiated astrocytomas (ranging from WHO grade
s I to IV) were stained immunohistochemic ally using the avidin-biotin
horseradish peroxidase technique. Two antibodies, PC10 and MIB-1, wer
e used to establish the proliferating labelling indices. PC10 identifi
es PCNA and MIB-1 recognises the Ki-67 antigen. Results-Both antibodie
s showed significantly higher labelling indices in the post-irradiated
specimens. However, in general, the Ki-67 indices were lower than tho
se for PCNA. MIB-1 immunoreactivity showed less variation and was more
intense than that seen with PC10. The discrepancy between the labelli
ng indices of the pre-irradiated and post-irradiated samples raises qu
estions about the evolution of astrocytomas and the effects of therape
utic intervention. Conclusions-The data may represent genetic alterati
ons, the natural tumour course, and/or the effect of radiation. Althou
gh both of the antibodies reflected the state of growth of neoplastic
cells in astrocytomas, MIB-1 was more reliable. A simple immunohistoch
emical method using proliferation markers does have an important role
in the future care of patients with astrocytoma.